GENE2CURE AUSTRALIA PTY LTD
ABN details
| ABN | 36 686 027 467 |
|---|---|
| ABN status | Active from 7 April 2025 |
| Entity name | GENE2CURE AUSTRALIA PTY LTD |
| Entity type | Australian Private Company |
| GST | Not registered |
| ACN / ARBN | 686 027 467 |
| Deductible gift recipient | No |
| Main business location | New South Wales 2021 · Other businesses in 2021 |
| Suburbs in postcode | Centennial Park, Moore Park, Paddington |
| Local government area | Sydney |
Source: ABR ABN Bulk Extract, 4 November 2026. Verify on ABN Lookup.
ASIC company registration
| ACN | 686 027 467 |
|---|---|
| Company type | Australian proprietary company |
| Company subclass | Proprietary company |
| Company class | Limited by shares |
| ASIC status | Registered |
| Registered with ASIC | 7 April 2025 |
Source: ASIC Company Dataset (data.gov.au), CC BY 3.0 AU. Search ASIC Connect.
Summary
GENE2CURE AUSTRALIA PTY LTD is an Australian Private Company with ABN 36 686 027 467, located in New South Wales 2021. The ABN is active since 7 April 2025.
It is not currently registered for GST. As a registered company it also has ACN 686 027 467, issued by ASIC.
ASIC lists it as a proprietary company, registered on 7 April 2025, with ASIC status registered.
Postcode 2021 covers Centennial Park, Moore Park, Paddington in the Sydney local government area.
Frequently asked questions
What is the ABN of GENE2CURE AUSTRALIA PTY LTD?
The ABN of GENE2CURE AUSTRALIA PTY LTD is 36 686 027 467.
Is the ABN of GENE2CURE AUSTRALIA PTY LTD active?
Yes. ABN 36 686 027 467 is active since 7 April 2025.
Is GENE2CURE AUSTRALIA PTY LTD registered for GST?
No, it is not currently registered for GST, so its invoices should not charge GST.
What is the ACN of GENE2CURE AUSTRALIA PTY LTD?
The ACN is 686 027 467.
When was GENE2CURE AUSTRALIA PTY LTD registered?
GENE2CURE AUSTRALIA PTY LTD was registered with ASIC on 7 April 2025. Its ASIC status is registered.
Where is GENE2CURE AUSTRALIA PTY LTD located?
Its main business location is in New South Wales, postcode 2021.